Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Asthma
Interventions
DRUG

Salmeterol/fluticasone propionate combination

Trial Locations (35)

4000

GSK Investigational Site, Liège

9000

GSK Investigational Site, Ghent

10559

GSK Investigational Site, Berlin

13353

GSK Investigational Site, Berlin

13359

GSK Investigational Site, Berlin

28006

GSK Investigational Site, Madrid

33100

GSK Investigational Site, Tampere

34295

GSK Investigational Site, Montpellier

37012

GSK Investigational Site, Bussolengo (VR)

40100

GSK Investigational Site, Jyväskylä

46017

GSK Investigational Site, Valencia

51014

GSK Investigational Site, Tartu

53123

GSK Investigational Site, Bonn

56124

GSK Investigational Site, Pisa

59042

GSK Investigational Site, Lille

60020

GSK Investigational Site, Torrette (AN)

71100

GSK Investigational Site, Foggia

74889

GSK Investigational Site, Sinsheim

84100

GSK Investigational Site, Salerno

86000 cedex

GSK Investigational Site, Poitiers

09126

GSK Investigational Site, Cagliari

LV 1003

GSK Investigational Site, Riga

LV 1035

GSK Investigational Site, Riga

4819 EV

GSK Investigational Site, Breda

9721 SW

GSK Investigational Site, Groningen

3844 DG

GSK Investigational Site, Harderwijk

5707 HA

GSK Investigational Site, Helmond

1624 NP

GSK Investigational Site, Hoorn

3435 CM

GSK Investigational Site, Nieuwegein

5504 DB

GSK Investigational Site, Veldhoven

08022

GSK Investigational Site, Barcelona

08221

GSK Investigational Site, Tarrasa, Barcelona

SE-413 45

GSK Investigational Site, Gothenburg

SE-585 81

GSK Investigational Site, Linköping

SE-221 85

GSK Investigational Site, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY